Mitchell Capital Management »

Corcept Therapeutics Incorporated shares owned by Mitchell Capital Management

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Mitchell Capital Management from 13F filings

Historical chart of Mitchell Capital Management investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Mitchell Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Mitchell Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.6M 56k 83.11
2025-06-30 $3.9M 56k 70.86
2025-03-31 $7.3M 64k 114.22

More positions owned by Mitchell Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Inc Class C cs (GOOG)
Broadcom (AVGO)
Facebook Inc cl a (META)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway (BRK.B)
Visa (V)
Wal-Mart Stores (WMT)
Goldman Sachs (GS)
MasterCard Incorporated (MA)
Crowdstrike Hldgs Inc cl a (CRWD)
Taiwan Semiconductor Mfg (TSM)

View all positions for Mitchell Capital Management

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated